nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—SSTR1—pancreatic cancer	0.26	0.351	CbGaD
Octreotide—SSTR3—pancreatic cancer	0.26	0.351	CbGaD
Octreotide—SSTR2—pancreatic cancer	0.221	0.298	CbGaD
Octreotide—MPO—superior mesenteric artery—pancreatic cancer	0.0235	0.665	CbGeAlD
Octreotide—SSTR4—digestive system—pancreatic cancer	0.0035	0.0988	CbGeAlD
Octreotide—SSTR1—pancreas—pancreatic cancer	0.00264	0.0745	CbGeAlD
Octreotide—SSTR2—pancreas—pancreatic cancer	0.00225	0.0634	CbGeAlD
Octreotide—SSTR2—digestive system—pancreatic cancer	0.00192	0.0541	CbGeAlD
Octreotide—Pasireotide—SSTR3—pancreatic cancer	0.0015	0.276	CrCbGaD
Octreotide—Pasireotide—SSTR1—pancreatic cancer	0.0015	0.276	CrCbGaD
Octreotide—Pasireotide—SSTR2—pancreatic cancer	0.00128	0.235	CrCbGaD
Octreotide—Vapreotide—SSTR2—pancreatic cancer	0.00109	0.2	CrCbGaD
Octreotide—MPO—pancreas—pancreatic cancer	0.00085	0.024	CbGeAlD
Octreotide—MPO—digestive system—pancreatic cancer	0.000726	0.0205	CbGeAlD
Octreotide—Desmopressin—PTGS2—pancreatic cancer	7.39e-05	0.0136	CrCbGaD
Octreotide—Weight decreased—Epirubicin—pancreatic cancer	5.28e-05	0.000483	CcSEcCtD
Octreotide—Hyperglycaemia—Epirubicin—pancreatic cancer	5.26e-05	0.000481	CcSEcCtD
Octreotide—Cough—Docetaxel—pancreatic cancer	5.26e-05	0.000481	CcSEcCtD
Octreotide—Hypersensitivity—Irinotecan—pancreatic cancer	5.24e-05	0.000479	CcSEcCtD
Octreotide—Pneumonia—Epirubicin—pancreatic cancer	5.23e-05	0.000479	CcSEcCtD
Octreotide—Convulsion—Docetaxel—pancreatic cancer	5.22e-05	0.000478	CcSEcCtD
Octreotide—Hypertension—Docetaxel—pancreatic cancer	5.2e-05	0.000476	CcSEcCtD
Octreotide—Drowsiness—Epirubicin—pancreatic cancer	5.2e-05	0.000476	CcSEcCtD
Octreotide—Bronchitis—Doxorubicin—pancreatic cancer	5.19e-05	0.000475	CcSEcCtD
Octreotide—Chest pain—Docetaxel—pancreatic cancer	5.13e-05	0.000469	CcSEcCtD
Octreotide—Arthralgia—Docetaxel—pancreatic cancer	5.13e-05	0.000469	CcSEcCtD
Octreotide—Myalgia—Docetaxel—pancreatic cancer	5.13e-05	0.000469	CcSEcCtD
Octreotide—Nausea—Sunitinib—pancreatic cancer	5.13e-05	0.000469	CcSEcCtD
Octreotide—Asthenia—Irinotecan—pancreatic cancer	5.1e-05	0.000467	CcSEcCtD
Octreotide—Neuropathy peripheral—Epirubicin—pancreatic cancer	5.1e-05	0.000466	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	5.09e-05	0.000466	CcSEcCtD
Octreotide—Jaundice—Epirubicin—pancreatic cancer	5.07e-05	0.000464	CcSEcCtD
Octreotide—Urinary tract infection—Epirubicin—pancreatic cancer	5.06e-05	0.000462	CcSEcCtD
Octreotide—Conjunctivitis—Epirubicin—pancreatic cancer	5.06e-05	0.000462	CcSEcCtD
Octreotide—Dysuria—Doxorubicin—pancreatic cancer	5.05e-05	0.000462	CcSEcCtD
Octreotide—Hypersensitivity—Fluorouracil—pancreatic cancer	5.02e-05	0.000459	CcSEcCtD
Octreotide—Dry mouth—Docetaxel—pancreatic cancer	5.02e-05	0.000459	CcSEcCtD
Octreotide—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	5.02e-05	0.000459	CcSEcCtD
Octreotide—Pollakiuria—Doxorubicin—pancreatic cancer	4.99e-05	0.000456	CcSEcCtD
Octreotide—Asthenia—Gemcitabine—pancreatic cancer	4.97e-05	0.000455	CcSEcCtD
Octreotide—Haematuria—Epirubicin—pancreatic cancer	4.96e-05	0.000454	CcSEcCtD
Octreotide—Hepatobiliary disease—Epirubicin—pancreatic cancer	4.92e-05	0.00045	CcSEcCtD
Octreotide—Anaphylactic shock—Docetaxel—pancreatic cancer	4.92e-05	0.00045	CcSEcCtD
Octreotide—Oedema—Docetaxel—pancreatic cancer	4.92e-05	0.00045	CcSEcCtD
Octreotide—Weight increased—Doxorubicin—pancreatic cancer	4.91e-05	0.000449	CcSEcCtD
Octreotide—Epistaxis—Epirubicin—pancreatic cancer	4.91e-05	0.000449	CcSEcCtD
Octreotide—Pruritus—Gemcitabine—pancreatic cancer	4.9e-05	0.000449	CcSEcCtD
Octreotide—Infection—Docetaxel—pancreatic cancer	4.89e-05	0.000447	CcSEcCtD
Octreotide—Weight decreased—Doxorubicin—pancreatic cancer	4.88e-05	0.000447	CcSEcCtD
Octreotide—Sinusitis—Epirubicin—pancreatic cancer	4.88e-05	0.000446	CcSEcCtD
Octreotide—Hyperglycaemia—Doxorubicin—pancreatic cancer	4.87e-05	0.000445	CcSEcCtD
Octreotide—Diarrhoea—Irinotecan—pancreatic cancer	4.87e-05	0.000445	CcSEcCtD
Octreotide—Pneumonia—Doxorubicin—pancreatic cancer	4.84e-05	0.000443	CcSEcCtD
Octreotide—Shock—Docetaxel—pancreatic cancer	4.84e-05	0.000443	CcSEcCtD
Octreotide—Nervous system disorder—Docetaxel—pancreatic cancer	4.82e-05	0.000441	CcSEcCtD
Octreotide—Pruritus—Fluorouracil—pancreatic cancer	4.82e-05	0.000441	CcSEcCtD
Octreotide—Thrombocytopenia—Docetaxel—pancreatic cancer	4.81e-05	0.00044	CcSEcCtD
Octreotide—Drowsiness—Doxorubicin—pancreatic cancer	4.81e-05	0.00044	CcSEcCtD
Octreotide—Tachycardia—Docetaxel—pancreatic cancer	4.8e-05	0.000439	CcSEcCtD
Octreotide—Skin disorder—Docetaxel—pancreatic cancer	4.78e-05	0.000437	CcSEcCtD
Octreotide—Bradycardia—Epirubicin—pancreatic cancer	4.75e-05	0.000435	CcSEcCtD
Octreotide—Diarrhoea—Gemcitabine—pancreatic cancer	4.74e-05	0.000434	CcSEcCtD
Octreotide—Neuropathy peripheral—Doxorubicin—pancreatic cancer	4.72e-05	0.000432	CcSEcCtD
Octreotide—Dizziness—Irinotecan—pancreatic cancer	4.7e-05	0.00043	CcSEcCtD
Octreotide—Jaundice—Doxorubicin—pancreatic cancer	4.69e-05	0.000429	CcSEcCtD
Octreotide—Anorexia—Docetaxel—pancreatic cancer	4.69e-05	0.000429	CcSEcCtD
Octreotide—Rhinitis—Epirubicin—pancreatic cancer	4.68e-05	0.000428	CcSEcCtD
Octreotide—Urinary tract infection—Doxorubicin—pancreatic cancer	4.68e-05	0.000428	CcSEcCtD
Octreotide—Conjunctivitis—Doxorubicin—pancreatic cancer	4.68e-05	0.000428	CcSEcCtD
Octreotide—Hepatitis—Epirubicin—pancreatic cancer	4.67e-05	0.000427	CcSEcCtD
Octreotide—Diarrhoea—Fluorouracil—pancreatic cancer	4.66e-05	0.000426	CcSEcCtD
Octreotide—Hypoaesthesia—Epirubicin—pancreatic cancer	4.65e-05	0.000425	CcSEcCtD
Octreotide—Pharyngitis—Epirubicin—pancreatic cancer	4.63e-05	0.000424	CcSEcCtD
Octreotide—Oedema peripheral—Epirubicin—pancreatic cancer	4.6e-05	0.000421	CcSEcCtD
Octreotide—Haematuria—Doxorubicin—pancreatic cancer	4.59e-05	0.00042	CcSEcCtD
Octreotide—Hepatobiliary disease—Doxorubicin—pancreatic cancer	4.55e-05	0.000416	CcSEcCtD
Octreotide—Epistaxis—Doxorubicin—pancreatic cancer	4.54e-05	0.000415	CcSEcCtD
Octreotide—Vomiting—Irinotecan—pancreatic cancer	4.52e-05	0.000414	CcSEcCtD
Octreotide—Sinusitis—Doxorubicin—pancreatic cancer	4.51e-05	0.000413	CcSEcCtD
Octreotide—Dizziness—Fluorouracil—pancreatic cancer	4.51e-05	0.000412	CcSEcCtD
Octreotide—Visual impairment—Epirubicin—pancreatic cancer	4.5e-05	0.000412	CcSEcCtD
Octreotide—Rash—Irinotecan—pancreatic cancer	4.49e-05	0.00041	CcSEcCtD
Octreotide—Dermatitis—Irinotecan—pancreatic cancer	4.48e-05	0.00041	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	4.48e-05	0.00041	CcSEcCtD
Octreotide—Headache—Irinotecan—pancreatic cancer	4.46e-05	0.000408	CcSEcCtD
Octreotide—Insomnia—Docetaxel—pancreatic cancer	4.45e-05	0.000407	CcSEcCtD
Octreotide—Paraesthesia—Docetaxel—pancreatic cancer	4.42e-05	0.000404	CcSEcCtD
Octreotide—Vomiting—Gemcitabine—pancreatic cancer	4.41e-05	0.000403	CcSEcCtD
Octreotide—Bradycardia—Doxorubicin—pancreatic cancer	4.4e-05	0.000402	CcSEcCtD
Octreotide—Dyspnoea—Docetaxel—pancreatic cancer	4.38e-05	0.000401	CcSEcCtD
Octreotide—Somnolence—Docetaxel—pancreatic cancer	4.37e-05	0.0004	CcSEcCtD
Octreotide—Rash—Gemcitabine—pancreatic cancer	4.37e-05	0.0004	CcSEcCtD
Octreotide—Dermatitis—Gemcitabine—pancreatic cancer	4.37e-05	0.000399	CcSEcCtD
Octreotide—Tinnitus—Epirubicin—pancreatic cancer	4.35e-05	0.000398	CcSEcCtD
Octreotide—Headache—Gemcitabine—pancreatic cancer	4.34e-05	0.000397	CcSEcCtD
Octreotide—Flushing—Epirubicin—pancreatic cancer	4.33e-05	0.000396	CcSEcCtD
Octreotide—Cardiac disorder—Epirubicin—pancreatic cancer	4.33e-05	0.000396	CcSEcCtD
Octreotide—Vomiting—Fluorouracil—pancreatic cancer	4.33e-05	0.000396	CcSEcCtD
Octreotide—Rhinitis—Doxorubicin—pancreatic cancer	4.33e-05	0.000396	CcSEcCtD
Octreotide—Dyspepsia—Docetaxel—pancreatic cancer	4.33e-05	0.000396	CcSEcCtD
Octreotide—Hepatitis—Doxorubicin—pancreatic cancer	4.32e-05	0.000395	CcSEcCtD
Octreotide—Hypoaesthesia—Doxorubicin—pancreatic cancer	4.3e-05	0.000393	CcSEcCtD
Octreotide—Rash—Fluorouracil—pancreatic cancer	4.3e-05	0.000393	CcSEcCtD
Octreotide—Dermatitis—Fluorouracil—pancreatic cancer	4.29e-05	0.000393	CcSEcCtD
Octreotide—Pharyngitis—Doxorubicin—pancreatic cancer	4.29e-05	0.000392	CcSEcCtD
Octreotide—Decreased appetite—Docetaxel—pancreatic cancer	4.27e-05	0.000391	CcSEcCtD
Octreotide—Headache—Fluorouracil—pancreatic cancer	4.27e-05	0.00039	CcSEcCtD
Octreotide—Oedema peripheral—Doxorubicin—pancreatic cancer	4.26e-05	0.000389	CcSEcCtD
Octreotide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	4.25e-05	0.000388	CcSEcCtD
Octreotide—Fatigue—Docetaxel—pancreatic cancer	4.24e-05	0.000388	CcSEcCtD
Octreotide—Nausea—Irinotecan—pancreatic cancer	4.23e-05	0.000387	CcSEcCtD
Octreotide—Immune system disorder—Epirubicin—pancreatic cancer	4.22e-05	0.000386	CcSEcCtD
Octreotide—Pain—Docetaxel—pancreatic cancer	4.21e-05	0.000385	CcSEcCtD
Octreotide—Constipation—Docetaxel—pancreatic cancer	4.21e-05	0.000385	CcSEcCtD
Octreotide—Arrhythmia—Epirubicin—pancreatic cancer	4.17e-05	0.000382	CcSEcCtD
Octreotide—Visual impairment—Doxorubicin—pancreatic cancer	4.16e-05	0.000381	CcSEcCtD
Octreotide—Alopecia—Epirubicin—pancreatic cancer	4.13e-05	0.000377	CcSEcCtD
Octreotide—Nausea—Gemcitabine—pancreatic cancer	4.12e-05	0.000377	CcSEcCtD
Octreotide—Mental disorder—Epirubicin—pancreatic cancer	4.09e-05	0.000374	CcSEcCtD
Octreotide—Malnutrition—Epirubicin—pancreatic cancer	4.06e-05	0.000372	CcSEcCtD
Octreotide—Erythema—Epirubicin—pancreatic cancer	4.06e-05	0.000372	CcSEcCtD
Octreotide—Feeling abnormal—Docetaxel—pancreatic cancer	4.05e-05	0.000371	CcSEcCtD
Octreotide—Nausea—Fluorouracil—pancreatic cancer	4.05e-05	0.00037	CcSEcCtD
Octreotide—Tinnitus—Doxorubicin—pancreatic cancer	4.03e-05	0.000368	CcSEcCtD
Octreotide—Gastrointestinal pain—Docetaxel—pancreatic cancer	4.02e-05	0.000368	CcSEcCtD
Octreotide—Flushing—Doxorubicin—pancreatic cancer	4.01e-05	0.000367	CcSEcCtD
Octreotide—Cardiac disorder—Doxorubicin—pancreatic cancer	4.01e-05	0.000367	CcSEcCtD
Octreotide—Flatulence—Epirubicin—pancreatic cancer	4e-05	0.000366	CcSEcCtD
Octreotide—Tension—Epirubicin—pancreatic cancer	3.99e-05	0.000365	CcSEcCtD
Octreotide—Nervousness—Epirubicin—pancreatic cancer	3.95e-05	0.000361	CcSEcCtD
Octreotide—Back pain—Epirubicin—pancreatic cancer	3.93e-05	0.00036	CcSEcCtD
Octreotide—Muscle spasms—Epirubicin—pancreatic cancer	3.91e-05	0.000357	CcSEcCtD
Octreotide—Immune system disorder—Doxorubicin—pancreatic cancer	3.9e-05	0.000357	CcSEcCtD
Octreotide—Body temperature increased—Docetaxel—pancreatic cancer	3.89e-05	0.000356	CcSEcCtD
Octreotide—Abdominal pain—Docetaxel—pancreatic cancer	3.89e-05	0.000356	CcSEcCtD
Octreotide—Arrhythmia—Doxorubicin—pancreatic cancer	3.86e-05	0.000353	CcSEcCtD
Octreotide—Vision blurred—Epirubicin—pancreatic cancer	3.83e-05	0.00035	CcSEcCtD
Octreotide—Alopecia—Doxorubicin—pancreatic cancer	3.82e-05	0.000349	CcSEcCtD
Octreotide—Mental disorder—Doxorubicin—pancreatic cancer	3.78e-05	0.000346	CcSEcCtD
Octreotide—Ill-defined disorder—Epirubicin—pancreatic cancer	3.77e-05	0.000345	CcSEcCtD
Octreotide—Malnutrition—Doxorubicin—pancreatic cancer	3.76e-05	0.000344	CcSEcCtD
Octreotide—Erythema—Doxorubicin—pancreatic cancer	3.76e-05	0.000344	CcSEcCtD
Octreotide—Anaemia—Epirubicin—pancreatic cancer	3.76e-05	0.000344	CcSEcCtD
Octreotide—Agitation—Epirubicin—pancreatic cancer	3.73e-05	0.000342	CcSEcCtD
Octreotide—Flatulence—Doxorubicin—pancreatic cancer	3.71e-05	0.000339	CcSEcCtD
Octreotide—Tension—Doxorubicin—pancreatic cancer	3.69e-05	0.000338	CcSEcCtD
Octreotide—Malaise—Epirubicin—pancreatic cancer	3.67e-05	0.000335	CcSEcCtD
Octreotide—Nervousness—Doxorubicin—pancreatic cancer	3.65e-05	0.000334	CcSEcCtD
Octreotide—Vertigo—Epirubicin—pancreatic cancer	3.65e-05	0.000334	CcSEcCtD
Octreotide—Syncope—Epirubicin—pancreatic cancer	3.64e-05	0.000333	CcSEcCtD
Octreotide—Back pain—Doxorubicin—pancreatic cancer	3.64e-05	0.000333	CcSEcCtD
Octreotide—Hypersensitivity—Docetaxel—pancreatic cancer	3.62e-05	0.000331	CcSEcCtD
Octreotide—Muscle spasms—Doxorubicin—pancreatic cancer	3.62e-05	0.000331	CcSEcCtD
Octreotide—Palpitations—Epirubicin—pancreatic cancer	3.59e-05	0.000329	CcSEcCtD
Octreotide—Loss of consciousness—Epirubicin—pancreatic cancer	3.57e-05	0.000327	CcSEcCtD
Octreotide—Cough—Epirubicin—pancreatic cancer	3.55e-05	0.000324	CcSEcCtD
Octreotide—Vision blurred—Doxorubicin—pancreatic cancer	3.54e-05	0.000324	CcSEcCtD
Octreotide—Asthenia—Docetaxel—pancreatic cancer	3.53e-05	0.000323	CcSEcCtD
Octreotide—Convulsion—Epirubicin—pancreatic cancer	3.52e-05	0.000322	CcSEcCtD
Octreotide—Hypertension—Epirubicin—pancreatic cancer	3.51e-05	0.000321	CcSEcCtD
Octreotide—Ill-defined disorder—Doxorubicin—pancreatic cancer	3.49e-05	0.000319	CcSEcCtD
Octreotide—Pruritus—Docetaxel—pancreatic cancer	3.48e-05	0.000318	CcSEcCtD
Octreotide—Anaemia—Doxorubicin—pancreatic cancer	3.48e-05	0.000318	CcSEcCtD
Octreotide—Arthralgia—Epirubicin—pancreatic cancer	3.46e-05	0.000317	CcSEcCtD
Octreotide—Chest pain—Epirubicin—pancreatic cancer	3.46e-05	0.000317	CcSEcCtD
Octreotide—Myalgia—Epirubicin—pancreatic cancer	3.46e-05	0.000317	CcSEcCtD
Octreotide—Agitation—Doxorubicin—pancreatic cancer	3.46e-05	0.000316	CcSEcCtD
Octreotide—Anxiety—Epirubicin—pancreatic cancer	3.45e-05	0.000315	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	3.44e-05	0.000314	CcSEcCtD
Octreotide—Discomfort—Epirubicin—pancreatic cancer	3.42e-05	0.000313	CcSEcCtD
Octreotide—Malaise—Doxorubicin—pancreatic cancer	3.39e-05	0.00031	CcSEcCtD
Octreotide—Dry mouth—Epirubicin—pancreatic cancer	3.38e-05	0.00031	CcSEcCtD
Octreotide—Vertigo—Doxorubicin—pancreatic cancer	3.38e-05	0.000309	CcSEcCtD
Octreotide—Syncope—Doxorubicin—pancreatic cancer	3.37e-05	0.000309	CcSEcCtD
Octreotide—Diarrhoea—Docetaxel—pancreatic cancer	3.36e-05	0.000308	CcSEcCtD
Octreotide—Palpitations—Doxorubicin—pancreatic cancer	3.32e-05	0.000304	CcSEcCtD
Octreotide—Oedema—Epirubicin—pancreatic cancer	3.32e-05	0.000303	CcSEcCtD
Octreotide—Anaphylactic shock—Epirubicin—pancreatic cancer	3.32e-05	0.000303	CcSEcCtD
Octreotide—Loss of consciousness—Doxorubicin—pancreatic cancer	3.31e-05	0.000302	CcSEcCtD
Octreotide—Infection—Epirubicin—pancreatic cancer	3.3e-05	0.000301	CcSEcCtD
Octreotide—Cough—Doxorubicin—pancreatic cancer	3.28e-05	0.0003	CcSEcCtD
Octreotide—Shock—Epirubicin—pancreatic cancer	3.26e-05	0.000299	CcSEcCtD
Octreotide—Convulsion—Doxorubicin—pancreatic cancer	3.26e-05	0.000298	CcSEcCtD
Octreotide—Nervous system disorder—Epirubicin—pancreatic cancer	3.25e-05	0.000298	CcSEcCtD
Octreotide—Dizziness—Docetaxel—pancreatic cancer	3.25e-05	0.000297	CcSEcCtD
Octreotide—Thrombocytopenia—Epirubicin—pancreatic cancer	3.25e-05	0.000297	CcSEcCtD
Octreotide—Hypertension—Doxorubicin—pancreatic cancer	3.25e-05	0.000297	CcSEcCtD
Octreotide—Tachycardia—Epirubicin—pancreatic cancer	3.24e-05	0.000296	CcSEcCtD
Octreotide—Skin disorder—Epirubicin—pancreatic cancer	3.22e-05	0.000295	CcSEcCtD
Octreotide—Hyperhidrosis—Epirubicin—pancreatic cancer	3.21e-05	0.000293	CcSEcCtD
Octreotide—Myalgia—Doxorubicin—pancreatic cancer	3.2e-05	0.000293	CcSEcCtD
Octreotide—Chest pain—Doxorubicin—pancreatic cancer	3.2e-05	0.000293	CcSEcCtD
Octreotide—Arthralgia—Doxorubicin—pancreatic cancer	3.2e-05	0.000293	CcSEcCtD
Octreotide—Anxiety—Doxorubicin—pancreatic cancer	3.19e-05	0.000292	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	3.18e-05	0.000291	CcSEcCtD
Octreotide—Discomfort—Doxorubicin—pancreatic cancer	3.16e-05	0.000289	CcSEcCtD
Octreotide—Anorexia—Epirubicin—pancreatic cancer	3.16e-05	0.000289	CcSEcCtD
Octreotide—Dry mouth—Doxorubicin—pancreatic cancer	3.13e-05	0.000286	CcSEcCtD
Octreotide—Vomiting—Docetaxel—pancreatic cancer	3.13e-05	0.000286	CcSEcCtD
Octreotide—Rash—Docetaxel—pancreatic cancer	3.1e-05	0.000284	CcSEcCtD
Octreotide—Dermatitis—Docetaxel—pancreatic cancer	3.1e-05	0.000283	CcSEcCtD
Octreotide—Headache—Docetaxel—pancreatic cancer	3.08e-05	0.000282	CcSEcCtD
Octreotide—Oedema—Doxorubicin—pancreatic cancer	3.07e-05	0.000281	CcSEcCtD
Octreotide—Anaphylactic shock—Doxorubicin—pancreatic cancer	3.07e-05	0.000281	CcSEcCtD
Octreotide—Infection—Doxorubicin—pancreatic cancer	3.05e-05	0.000279	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	3.02e-05	0.000276	CcSEcCtD
Octreotide—Shock—Doxorubicin—pancreatic cancer	3.02e-05	0.000276	CcSEcCtD
Octreotide—Nervous system disorder—Doxorubicin—pancreatic cancer	3.01e-05	0.000275	CcSEcCtD
Octreotide—Thrombocytopenia—Doxorubicin—pancreatic cancer	3e-05	0.000275	CcSEcCtD
Octreotide—Insomnia—Epirubicin—pancreatic cancer	3e-05	0.000274	CcSEcCtD
Octreotide—Tachycardia—Doxorubicin—pancreatic cancer	3e-05	0.000274	CcSEcCtD
Octreotide—Skin disorder—Doxorubicin—pancreatic cancer	2.98e-05	0.000273	CcSEcCtD
Octreotide—Paraesthesia—Epirubicin—pancreatic cancer	2.98e-05	0.000272	CcSEcCtD
Octreotide—Hyperhidrosis—Doxorubicin—pancreatic cancer	2.97e-05	0.000271	CcSEcCtD
Octreotide—Dyspnoea—Epirubicin—pancreatic cancer	2.96e-05	0.000271	CcSEcCtD
Octreotide—Somnolence—Epirubicin—pancreatic cancer	2.95e-05	0.00027	CcSEcCtD
Octreotide—Anorexia—Doxorubicin—pancreatic cancer	2.93e-05	0.000268	CcSEcCtD
Octreotide—Nausea—Docetaxel—pancreatic cancer	2.92e-05	0.000267	CcSEcCtD
Octreotide—Dyspepsia—Epirubicin—pancreatic cancer	2.92e-05	0.000267	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—SHH—pancreatic cancer	2.9e-05	0.000265	CbGpPWpGaD
Octreotide—Decreased appetite—Epirubicin—pancreatic cancer	2.88e-05	0.000264	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—NOTCH4—pancreatic cancer	2.88e-05	0.000264	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CG—pancreatic cancer	2.87e-05	0.000262	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	2.86e-05	0.000262	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—IAPP—pancreatic cancer	2.86e-05	0.000262	CbGpPWpGaD
Octreotide—Fatigue—Epirubicin—pancreatic cancer	2.86e-05	0.000262	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—GCG—pancreatic cancer	2.85e-05	0.000261	CbGpPWpGaD
Octreotide—Pain—Epirubicin—pancreatic cancer	2.84e-05	0.000259	CcSEcCtD
Octreotide—Constipation—Epirubicin—pancreatic cancer	2.84e-05	0.000259	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CNR1—pancreatic cancer	2.83e-05	0.000259	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	2.8e-05	0.000256	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—CXCL8—pancreatic cancer	2.79e-05	0.000255	CbGpPWpGaD
Octreotide—Insomnia—Doxorubicin—pancreatic cancer	2.78e-05	0.000254	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.78e-05	0.000254	CbGpPWpGaD
Octreotide—Paraesthesia—Doxorubicin—pancreatic cancer	2.76e-05	0.000252	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—PIK3CG—pancreatic cancer	2.75e-05	0.000252	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTHLH—pancreatic cancer	2.75e-05	0.000251	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTCH1—pancreatic cancer	2.75e-05	0.000251	CbGpPWpGaD
Octreotide—Dyspnoea—Doxorubicin—pancreatic cancer	2.74e-05	0.00025	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—GCG—pancreatic cancer	2.73e-05	0.00025	CbGpPWpGaD
Octreotide—Feeling abnormal—Epirubicin—pancreatic cancer	2.73e-05	0.00025	CcSEcCtD
Octreotide—Somnolence—Doxorubicin—pancreatic cancer	2.73e-05	0.00025	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—SST—pancreatic cancer	2.72e-05	0.000249	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AGTR1—pancreatic cancer	2.72e-05	0.000249	CbGpPWpGaD
Octreotide—Gastrointestinal pain—Epirubicin—pancreatic cancer	2.71e-05	0.000248	CcSEcCtD
Octreotide—Dyspepsia—Doxorubicin—pancreatic cancer	2.7e-05	0.000247	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.68e-05	0.000246	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—STK11—pancreatic cancer	2.68e-05	0.000246	CbGpPWpGaD
Octreotide—Decreased appetite—Doxorubicin—pancreatic cancer	2.67e-05	0.000244	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—JAG1—pancreatic cancer	2.66e-05	0.000244	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.66e-05	0.000244	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOTCH3—pancreatic cancer	2.65e-05	0.000243	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TERT—pancreatic cancer	2.65e-05	0.000243	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	2.65e-05	0.000242	CcSEcCtD
Octreotide—Fatigue—Doxorubicin—pancreatic cancer	2.65e-05	0.000242	CcSEcCtD
Octreotide—Urticaria—Epirubicin—pancreatic cancer	2.64e-05	0.000241	CcSEcCtD
Octreotide—Constipation—Doxorubicin—pancreatic cancer	2.62e-05	0.00024	CcSEcCtD
Octreotide—Pain—Doxorubicin—pancreatic cancer	2.62e-05	0.00024	CcSEcCtD
Octreotide—Body temperature increased—Epirubicin—pancreatic cancer	2.62e-05	0.00024	CcSEcCtD
Octreotide—Abdominal pain—Epirubicin—pancreatic cancer	2.62e-05	0.00024	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—AGTR1—pancreatic cancer	2.61e-05	0.000239	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—STK11—pancreatic cancer	2.57e-05	0.000235	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HIF1A—pancreatic cancer	2.54e-05	0.000232	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TSC2—pancreatic cancer	2.53e-05	0.000232	CbGpPWpGaD
Octreotide—Feeling abnormal—Doxorubicin—pancreatic cancer	2.53e-05	0.000231	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—PIK3CD—pancreatic cancer	2.52e-05	0.000231	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SST—pancreatic cancer	2.51e-05	0.00023	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CNR1—pancreatic cancer	2.51e-05	0.00023	CbGpPWpGaD
Octreotide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	2.51e-05	0.00023	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.48e-05	0.000227	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—APOE—pancreatic cancer	2.48e-05	0.000227	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—JAG1—pancreatic cancer	2.46e-05	0.000225	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOTCH3—pancreatic cancer	2.45e-05	0.000224	CbGpPWpGaD
Octreotide—Hypersensitivity—Epirubicin—pancreatic cancer	2.44e-05	0.000224	CcSEcCtD
Octreotide—Urticaria—Doxorubicin—pancreatic cancer	2.44e-05	0.000223	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—PIK3CG—pancreatic cancer	2.44e-05	0.000223	CbGpPWpGaD
Octreotide—Abdominal pain—Doxorubicin—pancreatic cancer	2.43e-05	0.000222	CcSEcCtD
Octreotide—Body temperature increased—Doxorubicin—pancreatic cancer	2.43e-05	0.000222	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—GCG—pancreatic cancer	2.43e-05	0.000222	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KDR—pancreatic cancer	2.43e-05	0.000222	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.42e-05	0.000221	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.42e-05	0.000221	CbGpPWpGaD
Octreotide—Asthenia—Epirubicin—pancreatic cancer	2.38e-05	0.000218	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.36e-05	0.000216	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SMAD4—pancreatic cancer	2.35e-05	0.000215	CbGpPWpGaD
Octreotide—Pruritus—Epirubicin—pancreatic cancer	2.35e-05	0.000215	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—CXCL8—pancreatic cancer	2.32e-05	0.000213	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.32e-05	0.000212	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CNR1—pancreatic cancer	2.32e-05	0.000212	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AGTR1—pancreatic cancer	2.31e-05	0.000212	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NFKBIA—pancreatic cancer	2.31e-05	0.000211	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HES1—pancreatic cancer	2.29e-05	0.00021	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NOTCH1—pancreatic cancer	2.28e-05	0.000209	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STK11—pancreatic cancer	2.28e-05	0.000209	CbGpPWpGaD
Octreotide—Diarrhoea—Epirubicin—pancreatic cancer	2.27e-05	0.000208	CcSEcCtD
Octreotide—Hypersensitivity—Doxorubicin—pancreatic cancer	2.26e-05	0.000207	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—SMAD4—pancreatic cancer	2.25e-05	0.000206	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CG—pancreatic cancer	2.25e-05	0.000206	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—GCG—pancreatic cancer	2.24e-05	0.000205	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CG—pancreatic cancer	2.23e-05	0.000205	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—NRAS—pancreatic cancer	2.23e-05	0.000205	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.23e-05	0.000204	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EGF—pancreatic cancer	2.21e-05	0.000202	CbGpPWpGaD
Octreotide—Asthenia—Doxorubicin—pancreatic cancer	2.2e-05	0.000201	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—HES1—pancreatic cancer	2.2e-05	0.000201	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CB—pancreatic cancer	2.2e-05	0.000201	CbGpPWpGaD
Octreotide—Dizziness—Epirubicin—pancreatic cancer	2.19e-05	0.000201	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.18e-05	0.000199	CbGpPWpGaD
Octreotide—Pruritus—Doxorubicin—pancreatic cancer	2.17e-05	0.000199	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—PIK3CD—pancreatic cancer	2.14e-05	0.000196	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AGTR1—pancreatic cancer	2.14e-05	0.000195	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CXCL8—pancreatic cancer	2.11e-05	0.000193	CbGpPWpGaD
Octreotide—Vomiting—Epirubicin—pancreatic cancer	2.11e-05	0.000193	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.11e-05	0.000193	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STK11—pancreatic cancer	2.1e-05	0.000193	CbGpPWpGaD
Octreotide—Diarrhoea—Doxorubicin—pancreatic cancer	2.1e-05	0.000192	CcSEcCtD
Octreotide—Rash—Epirubicin—pancreatic cancer	2.09e-05	0.000191	CcSEcCtD
Octreotide—Dermatitis—Epirubicin—pancreatic cancer	2.09e-05	0.000191	CcSEcCtD
Octreotide—Headache—Epirubicin—pancreatic cancer	2.08e-05	0.00019	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.06e-05	0.000188	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—EGFR—pancreatic cancer	2.04e-05	0.000186	CbGpPWpGaD
Octreotide—Dizziness—Doxorubicin—pancreatic cancer	2.03e-05	0.000186	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—CXCL8—pancreatic cancer	2.02e-05	0.000185	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TERT—pancreatic cancer	2.01e-05	0.000184	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SMAD4—pancreatic cancer	2e-05	0.000183	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.98e-05	0.000181	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCL8—pancreatic cancer	1.98e-05	0.000181	CbGpPWpGaD
Octreotide—Nausea—Epirubicin—pancreatic cancer	1.97e-05	0.00018	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—PIK3CD—pancreatic cancer	1.96e-05	0.00018	CbGpPWpGaD
Octreotide—Vomiting—Doxorubicin—pancreatic cancer	1.95e-05	0.000179	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—HES1—pancreatic cancer	1.95e-05	0.000179	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.95e-05	0.000178	CbGpPWpGaD
Octreotide—Rash—Doxorubicin—pancreatic cancer	1.94e-05	0.000177	CcSEcCtD
Octreotide—Dermatitis—Doxorubicin—pancreatic cancer	1.93e-05	0.000177	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—TERT—pancreatic cancer	1.93e-05	0.000176	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—KRAS—pancreatic cancer	1.92e-05	0.000176	CbGpPWpGaD
Octreotide—Headache—Doxorubicin—pancreatic cancer	1.92e-05	0.000176	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—HIF1A—pancreatic cancer	1.92e-05	0.000176	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TSC2—pancreatic cancer	1.92e-05	0.000176	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.9e-05	0.000174	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APOE—pancreatic cancer	1.88e-05	0.000172	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CB—pancreatic cancer	1.87e-05	0.000171	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SMAD4—pancreatic cancer	1.84e-05	0.000169	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HIF1A—pancreatic cancer	1.84e-05	0.000169	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TSC2—pancreatic cancer	1.84e-05	0.000168	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KDR—pancreatic cancer	1.84e-05	0.000168	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.82e-05	0.000167	CbGpPWpGaD
Octreotide—Nausea—Doxorubicin—pancreatic cancer	1.82e-05	0.000167	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—HES1—pancreatic cancer	1.8e-05	0.000165	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOE—pancreatic cancer	1.8e-05	0.000165	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CXCL8—pancreatic cancer	1.79e-05	0.000164	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PIK3CA—pancreatic cancer	1.77e-05	0.000162	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KDR—pancreatic cancer	1.76e-05	0.000161	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NFKBIA—pancreatic cancer	1.75e-05	0.00016	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NOTCH1—pancreatic cancer	1.73e-05	0.000159	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.72e-05	0.000158	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CB—pancreatic cancer	1.71e-05	0.000157	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TERT—pancreatic cancer	1.71e-05	0.000156	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CG—pancreatic cancer	1.69e-05	0.000155	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—NRAS—pancreatic cancer	1.69e-05	0.000155	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NFKBIA—pancreatic cancer	1.68e-05	0.000153	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGF—pancreatic cancer	1.67e-05	0.000153	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NOTCH1—pancreatic cancer	1.66e-05	0.000152	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCL8—pancreatic cancer	1.66e-05	0.000152	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL8—pancreatic cancer	1.65e-05	0.000151	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—HRAS—pancreatic cancer	1.63e-05	0.00015	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HIF1A—pancreatic cancer	1.63e-05	0.00015	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TSC2—pancreatic cancer	1.63e-05	0.000149	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CG—pancreatic cancer	1.62e-05	0.000149	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—NRAS—pancreatic cancer	1.62e-05	0.000149	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGF—pancreatic cancer	1.6e-05	0.000147	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOE—pancreatic cancer	1.6e-05	0.000146	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—AKT1—pancreatic cancer	1.59e-05	0.000146	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TERT—pancreatic cancer	1.58e-05	0.000144	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CASP3—pancreatic cancer	1.57e-05	0.000144	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KDR—pancreatic cancer	1.56e-05	0.000143	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—EGFR—pancreatic cancer	1.54e-05	0.000141	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCND1—pancreatic cancer	1.53e-05	0.00014	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CTNNB1—pancreatic cancer	1.52e-05	0.000139	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HIF1A—pancreatic cancer	1.51e-05	0.000138	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TSC2—pancreatic cancer	1.5e-05	0.000138	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CD—pancreatic cancer	1.49e-05	0.000136	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—pancreatic cancer	1.49e-05	0.000136	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NFKBIA—pancreatic cancer	1.49e-05	0.000136	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTEN—pancreatic cancer	1.48e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—EGFR—pancreatic cancer	1.48e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.47e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOTCH1—pancreatic cancer	1.47e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOE—pancreatic cancer	1.47e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—KRAS—pancreatic cancer	1.46e-05	0.000133	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AKT1—pancreatic cancer	1.44e-05	0.000132	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KDR—pancreatic cancer	1.44e-05	0.000132	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CG—pancreatic cancer	1.44e-05	0.000132	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—NRAS—pancreatic cancer	1.44e-05	0.000132	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CD—pancreatic cancer	1.43e-05	0.000131	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGF—pancreatic cancer	1.42e-05	0.00013	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.41e-05	0.000129	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—KRAS—pancreatic cancer	1.4e-05	0.000128	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NFKBIA—pancreatic cancer	1.37e-05	0.000126	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SRC—pancreatic cancer	1.37e-05	0.000126	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOTCH1—pancreatic cancer	1.36e-05	0.000124	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CA—pancreatic cancer	1.34e-05	0.000123	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—pancreatic cancer	1.34e-05	0.000122	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CG—pancreatic cancer	1.33e-05	0.000122	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—NRAS—pancreatic cancer	1.33e-05	0.000122	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—STAT3—pancreatic cancer	1.32e-05	0.000121	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NRAS—pancreatic cancer	1.32e-05	0.000121	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGF—pancreatic cancer	1.31e-05	0.00012	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—EGFR—pancreatic cancer	1.31e-05	0.00012	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CB—pancreatic cancer	1.3e-05	0.000119	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.28e-05	0.000118	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CD—pancreatic cancer	1.27e-05	0.000116	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.25e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL8—pancreatic cancer	1.25e-05	0.000114	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CB—pancreatic cancer	1.24e-05	0.000114	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—KRAS—pancreatic cancer	1.24e-05	0.000113	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—HRAS—pancreatic cancer	1.24e-05	0.000113	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MYC—pancreatic cancer	1.23e-05	0.000113	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TGFB1—pancreatic cancer	1.23e-05	0.000112	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—EGFR—pancreatic cancer	1.21e-05	0.000111	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AKT1—pancreatic cancer	1.2e-05	0.00011	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EGFR—pancreatic cancer	1.2e-05	0.00011	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL8—pancreatic cancer	1.2e-05	0.000109	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CASP3—pancreatic cancer	1.19e-05	0.000109	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—HRAS—pancreatic cancer	1.19e-05	0.000109	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CD—pancreatic cancer	1.17e-05	0.000107	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCND1—pancreatic cancer	1.16e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.16e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AKT1—pancreatic cancer	1.15e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CTNNB1—pancreatic cancer	1.15e-05	0.000105	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CASP3—pancreatic cancer	1.14e-05	0.000105	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—KRAS—pancreatic cancer	1.14e-05	0.000105	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CA—pancreatic cancer	1.14e-05	0.000104	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KRAS—pancreatic cancer	1.14e-05	0.000104	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—pancreatic cancer	1.13e-05	0.000103	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTEN—pancreatic cancer	1.12e-05	0.000103	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCND1—pancreatic cancer	1.11e-05	0.000102	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CB—pancreatic cancer	1.1e-05	0.000101	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CTNNB1—pancreatic cancer	1.1e-05	0.000101	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AKT1—pancreatic cancer	1.09e-05	0.0001	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—pancreatic cancer	1.08e-05	9.9e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTEN—pancreatic cancer	1.07e-05	9.84e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL8—pancreatic cancer	1.06e-05	9.71e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—HRAS—pancreatic cancer	1.05e-05	9.64e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.05e-05	9.62e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AKT1—pancreatic cancer	1.05e-05	9.6e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CA—pancreatic cancer	1.04e-05	9.56e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SRC—pancreatic cancer	1.04e-05	9.52e-05	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AKT1—pancreatic cancer	1.02e-05	9.38e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CB—pancreatic cancer	1.02e-05	9.32e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CASP3—pancreatic cancer	1.01e-05	9.29e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—pancreatic cancer	1.01e-05	9.27e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—pancreatic cancer	1.01e-05	9.24e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—STAT3—pancreatic cancer	1e-05	9.18e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NRAS—pancreatic cancer	1e-05	9.16e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SRC—pancreatic cancer	9.97e-06	9.13e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCND1—pancreatic cancer	9.88e-06	9.04e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL8—pancreatic cancer	9.78e-06	8.96e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CTNNB1—pancreatic cancer	9.78e-06	8.95e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HRAS—pancreatic cancer	9.72e-06	8.9e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—pancreatic cancer	9.71e-06	8.89e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HRAS—pancreatic cancer	9.66e-06	8.84e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—STAT3—pancreatic cancer	9.61e-06	8.8e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NRAS—pancreatic cancer	9.59e-06	8.78e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—pancreatic cancer	9.59e-06	8.78e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTEN—pancreatic cancer	9.53e-06	8.73e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AKT1—pancreatic cancer	9.45e-06	8.65e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CASP3—pancreatic cancer	9.37e-06	8.57e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MYC—pancreatic cancer	9.32e-06	8.53e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT1—pancreatic cancer	9.3e-06	8.51e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TGFB1—pancreatic cancer	9.3e-06	8.51e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCND1—pancreatic cancer	9.12e-06	8.35e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGFR—pancreatic cancer	9.11e-06	8.34e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CTNNB1—pancreatic cancer	9.03e-06	8.26e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MYC—pancreatic cancer	8.93e-06	8.18e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TGFB1—pancreatic cancer	8.91e-06	8.16e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—pancreatic cancer	8.85e-06	8.1e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SRC—pancreatic cancer	8.84e-06	8.09e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTEN—pancreatic cancer	8.8e-06	8.05e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGFR—pancreatic cancer	8.74e-06	8e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—pancreatic cancer	8.61e-06	7.88e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KRAS—pancreatic cancer	8.61e-06	7.88e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT1—pancreatic cancer	8.58e-06	7.86e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT1—pancreatic cancer	8.53e-06	7.81e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STAT3—pancreatic cancer	8.53e-06	7.81e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NRAS—pancreatic cancer	8.51e-06	7.79e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KRAS—pancreatic cancer	8.25e-06	7.56e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SRC—pancreatic cancer	8.16e-06	7.47e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—pancreatic cancer	7.95e-06	7.28e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MYC—pancreatic cancer	7.92e-06	7.25e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CA—pancreatic cancer	7.91e-06	7.24e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TGFB1—pancreatic cancer	7.9e-06	7.24e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STAT3—pancreatic cancer	7.87e-06	7.2e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NRAS—pancreatic cancer	7.85e-06	7.19e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGFR—pancreatic cancer	7.75e-06	7.09e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—pancreatic cancer	7.65e-06	7.01e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CA—pancreatic cancer	7.58e-06	6.94e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—pancreatic cancer	7.34e-06	6.72e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KRAS—pancreatic cancer	7.32e-06	6.7e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HRAS—pancreatic cancer	7.32e-06	6.7e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MYC—pancreatic cancer	7.31e-06	6.69e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TGFB1—pancreatic cancer	7.29e-06	6.68e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGFR—pancreatic cancer	7.15e-06	6.55e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HRAS—pancreatic cancer	7.02e-06	6.42e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KRAS—pancreatic cancer	6.76e-06	6.18e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CA—pancreatic cancer	6.73e-06	6.16e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—pancreatic cancer	6.51e-06	5.96e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT1—pancreatic cancer	6.46e-06	5.92e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HRAS—pancreatic cancer	6.22e-06	5.7e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CA—pancreatic cancer	6.21e-06	5.68e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT1—pancreatic cancer	6.2e-06	5.67e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—pancreatic cancer	6e-06	5.5e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HRAS—pancreatic cancer	5.74e-06	5.26e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT1—pancreatic cancer	5.49e-06	5.03e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT1—pancreatic cancer	5.07e-06	4.64e-05	CbGpPWpGaD
